top of page
Search

Awarded 2022 NIH/NCI R01 Grant

  • kyun09
  • Sep 24, 2022
  • 1 min read

Humbled and thrilled to receive our NIH/NCI R01 grant!

It is a 5-year $3.07M grant for a prospective clinical trial with our E-Slice assay to predict Triple Negative Breast Cancer patient treatment responses to standard of care.

Huge thanks to collaborators Dr. Kyuson Yun, Houston Methodist/Weill-Cornell Med, and Dr. Naoto Ueno at MD Anderson Cancer Center. #E-Slice #NIH #NCI # R01 #TNBC #MDACC #HMRI #Breastcancer #Immunotherapy #Cancertreatment #Precisiononcology

 
 
 

Comments


bottom of page